You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

methylprednisolone and cyclophosphamide

Showing 76 - 100 of 2,306
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Methylprednisone Administration, Intranasal Administration, Intravenous Administration Trial in Mexico City (Evaluation of

Completed
  • Methylprednisone Administration
  • +3 more
  • Evaluation of bioavailability of methylprednisolone succinate administered intravenously
  • Evaluation of bioavailability of methylprednisolone succinate administered intranasally
  • Mexico City, Mexico
    Universidad Nacional Autonoma de Mexico
Dec 13, 2022

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Minneapolis (drug, radiation,

Recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
May 21, 2021

Efficacy Trial in Beijing (Prednisone, ciclosporin and mycophenolate mofetil, Ponticelli Regimen)

Completed
  • Efficacy
  • Prednisone, ciclosporin and mycophenolate mofetil
  • Ponticelli Regimen
  • Beijing, Beijing, China
  • +1 more
Feb 2, 2022

Lupus Nephritis Trial in United States (VIB4920, Placebo for VIB4920)

Recruiting
  • Lupus Nephritis
  • La Jolla, California
  • +13 more
Jul 26, 2022

GVHD (GvHD) Trial in Cardiff (Thymoglobulin, Cyclophosphamide, Cyclosporine)

Recruiting
  • Graft Versus Host Disease (GvHD)
  • Cardiff, Wales, United Kingdom
    University Hospital of Wales
May 10, 2021

Meniere Disease Trial (Methylprednisolon, Placebo)

Not yet recruiting
  • Meniere Disease
  • (no location specified)
May 1, 2023

Caudal Block Trial (caudal block using dexamethasone, caudal block using methylprednisolone)

Not yet recruiting
  • Caudal Block
  • caudal block using dexamethasone
  • caudal block using methylprednisolone
  • (no location specified)
Jan 28, 2023

PD-1 Antibody, Hemophagocytic Lymphohistiocytosis, Epstein-Barr Virus Trial in Beijing (L-DEP and PD-1 antibody)

Not yet recruiting
  • PD-1 Antibody
  • +3 more
  • L-DEP and PD-1 antibody
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Mar 8, 2023

Microscopic Polyangiitis (MPA) Trial in Paris (Rituximab, )

Recruiting
  • Microscopic Polyangiitis (MPA)
  • Paris, France
    Cochin Hospital
Dec 22, 2021

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Sep 20, 2023

Relapsing Remitting Multiple Sclerosis Trial in Worldwide (Pleneva TM BGC20-0134, Placebo)

Terminated
  • Relapsing Remitting Multiple Sclerosis
  • Pleneva TM BGC20-0134
  • Placebo
  • Gent, Belgium
  • +34 more
Jun 2, 2022

Neuroblastoma Trial in Canada, United States (Sorafenib, Cyclophosphamide, Topotecan)

Active, not recruiting
  • Neuroblastoma
  • Los Angeles, California
  • +11 more
Jan 30, 2023

NSCLC Trial in Guangzhou (chest radiation, concurrent chemo, Methylprednisolone)

Terminated
  • Non-small Cell Lung Cancer
  • chest radiation
  • +2 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Nov 25, 2022

Elective Cardiac Surgery Trial in Ghent (Methylprednisolone, Placebo)

Completed
  • Elective Cardiac Surgery
  • Ghent, Belgium
    University Hospital Ghent
Dec 6, 2022

HIV, Burkitt's Lymphoma Trial in Italy (Induction Phase, Consolidation Phase (on day +50), Intensification phase)

Completed
  • HIV
  • Burkitt's Lymphoma
  • Induction Phase
  • +4 more
  • Aviano (PN), Italy
  • +7 more
Aug 2, 2022

Neuroblastoma Trial in Australia, Canada, United States (DFMO, Celecoxib, Cyclophosphamide)

Active, not recruiting
  • Neuroblastoma
  • Los Angeles, California
  • +12 more
Jan 30, 2023

Rhinitis, Allergic, Seasonal, Hay Fever, Pollen Allergy Trial in Lund (MethylPREDNISolone 40 Mg/mL Injectable Suspension, NaCl 9

Active, not recruiting
  • Rhinitis, Allergic, Seasonal
  • +3 more
  • MethylPREDNISolone 40 Mg/mL Injectable Suspension
  • NaCl 9 MG/ML Injectable Solution
  • Lund, Skane, Sweden
    Department of Lung-and Allergy Research
Jun 22, 2022

Influence of Timing PTCy in AlloSCT

Not yet recruiting
  • Cyclophosphamide Toxicity
  • Allogenic Haematopoetic Transplantation
  • (no location specified)
Jun 6, 2023

Hodgkin Disease Trial in Houston (ABVE-PC, DECA)

Active, not recruiting
  • Hodgkin Disease
  • Houston, Texas
    Texas Children's Hospital
Jan 19, 2022

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,

Not yet recruiting
  • Acute Myelogenous Leukemia
  • +17 more
  • Peripheral Blood Stem Cell Transplant
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Mar 27, 2023

Clinical Analysis of Juvenile Dermatomyositis Patients

Completed
  • Juvenile Dermatomyositis
  • observation
  • (no location specified)
Aug 18, 2022

Knee Osteoarthritis Trial (ACP Max™, Depo-Medrol®)

Not yet recruiting
  • Knee Osteoarthritis
  • ACP Max™
  • Depo-Medrol®
  • (no location specified)
Mar 1, 2023

Lupus Erythematosus, Systemic, Lupus Glomerulonephritis Trial in Santiago de Chile (MSC treatment, Standard of Care, Placebo)

Recruiting
  • Lupus Erythematosus, Systemic
  • Lupus Glomerulonephritis
  • MSC treatment
  • +2 more
  • Santiago de Chile, Región Metropolitana, Chile
  • +1 more
Nov 13, 2020

Breast Cancer Trial in Shanghai (Pegylated liposomal doxorubicin, Epirubicin, Cyclophosphamid)

Recruiting
  • Breast Cancer
  • Pegylated liposomal doxorubicin
  • +5 more
  • Shanghai, China
    Shanghai Pudong Hospital
Dec 11, 2022

Peripheral T Cell Lymphoma Trial (CHOP+selinexor+5-Azacitidine, CHOP+duvelisib+5-Azacitidine, CHOP+chidamide+tislelizumab)

Not yet recruiting
  • Peripheral T Cell Lymphoma
  • (no location specified)
Dec 29, 2022